PT-141, also known as Bremelanotide, is a synthetic peptide. Unlike traditional approaches that focus on the vascular system, PT-141 operates through the central nervous system and has been studied in clinical research.

Disclaimer:

All products on this site are for Research, Development use only. Products are Not for Human use of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.